Latest News

Explore the top dermatology conferences and meetings happening this month and let us know which ones you'll be attending!

FDA reviews phase 3 results and expanded BOTOX Cosmetic use for masseter prominence and nonsurgical jawline contouring, potentially becoming the first neurotoxin approved in the US for this indication.

This month’s podcasts highlight the latest clinical insights, emerging therapies, and evolving conversations shaping dermatology practice.

Catch up on the biggest clinical updates, expert insights, and exclusive interviews from Elevate-Derm Summer 2026 in San Diego, California.

In this edition of The Practice Playbook, learn incident-to rules, Mohs coding limits, NPI liability, and how audits and whistleblowers trigger FCA cases.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Catch Up on Coverage From Day 5 of the 3rd Annual Elevate-Derm Summer Conference

As we wrap up UV Safety Awareness Month, Kathleen Suozzi, MD, explains warning signs of sun damage, sunscreen myths, and new year-round protection tools—plus the newly FDA-approved bemotrizinol.

Catch Up on Coverage From Day 4 of the 3rd Annual Elevate-Derm Summer Conference

Faculty at Elevate-Derm Summer 2026 discussed the expanding role of oral JAK inhibitors in pediatric dermatology, emphasizing earlier intervention, individualized patient selection, safety monitoring, and family-centered counseling.

Learn more about the in-depth topics covered in the July 2026 digital issue of Dermatology Times.

In July's letter from the editor in chief, Christopher Bunick, MD, PhD, breaks down why dermatology clinicians should be skilled in wound care.

Catch Up on Coverage From Day 2 of the 3rd Annual Elevate-Derm Summer Conference